Figure 5From: Development and evaluation of a replicon particle vaccine expressing the E2 glycoprotein of bovine viral diarrhea virus (BVDV) in cattleMean clinical scores over the course of the study. Scores were based on presence of mild nasal discharge, mild ocular discharge, or mild depression. No differences were seen in clinical outcomes between low dose E2 RP and placebo controls in clinical disease.Back to article page